Clovis Oncology Probability of Future Pink Sheet Price Finishing Under 0.11
| CLVSQDelisted Stock | 0.12 0.02 20.00% |
Clovis |
Clovis Oncology Target Price Odds to finish below 0.11
The tendency of Clovis Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 0.11 or more in 90 days |
| 0.12 | 90 days | 0.11 | about 29.22 |
Based on a normal probability distribution, the odds of Clovis Oncology to drop to 0.11 or more in 90 days from now is about 29.22 (This Clovis Oncology probability density function shows the probability of Clovis Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Clovis Oncology price to stay between 0.11 and its current price of 0.12 at the end of the 90-day period is under 4.
Assuming the 90 days horizon Clovis Oncology has a beta of -5.8 suggesting as returns on its benchmark rise, returns on holding Clovis Oncology are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Clovis Oncology is expected to outperform its benchmark. Additionally Clovis Oncology has an alpha of 0.4749, implying that it can generate a 0.47 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Clovis Oncology Price Density |
| Price |
Predictive Modules for Clovis Oncology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Clovis Oncology. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Clovis Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Clovis Oncology Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Clovis Oncology is not an exception. The market had few large corrections towards the Clovis Oncology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Clovis Oncology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Clovis Oncology within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.47 | |
β | Beta against Dow Jones | -5.8 | |
σ | Overall volatility | 0.11 | |
Ir | Information ratio | -0.02 |
Clovis Oncology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Clovis Oncology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Clovis Oncology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Clovis Oncology is not yet fully synchronised with the market data | |
| Clovis Oncology has some characteristics of a very speculative penny stock | |
| Clovis Oncology has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 148.76 M. Net Loss for the year was (264.52 M) with profit before overhead, payroll, taxes, and interest of 115.3 M. | |
| Clovis Oncology generates negative cash flow from operations |
Clovis Oncology Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Clovis Pink Sheet often depends not only on the future outlook of the current and potential Clovis Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Clovis Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 129.1 M |
Clovis Oncology Technical Analysis
Clovis Oncology's future price can be derived by breaking down and analyzing its technical indicators over time. Clovis Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Clovis Oncology. In general, you should focus on analyzing Clovis Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Clovis Oncology Predictive Forecast Models
Clovis Oncology's time-series forecasting models is one of many Clovis Oncology's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Clovis Oncology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Clovis Oncology
Checking the ongoing alerts about Clovis Oncology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Clovis Oncology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Clovis Oncology is not yet fully synchronised with the market data | |
| Clovis Oncology has some characteristics of a very speculative penny stock | |
| Clovis Oncology has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 148.76 M. Net Loss for the year was (264.52 M) with profit before overhead, payroll, taxes, and interest of 115.3 M. | |
| Clovis Oncology generates negative cash flow from operations |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Clovis Pink Sheet
If you are still planning to invest in Clovis Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Clovis Oncology's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |